DUBLIN, Oct. 29, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the ...

The NIM Vital device is a nerve monitoring system to help physicians identify, confirm and watch nerve function to reduce the risk of nerve damage during head and neck surgery, the release said.

The FDA grants 510(k) clearance to Medtronic's (NYSE:MDT) NIM Vital nerve monitoring system which helps physicians to identify, confirm and monitor nerve function in order to reduce the risk of nerve ...

Intraoperative NIM nerve monitoring systems enable surgeons to identify, confirm, and monitor motor nerve function to help reduce the risk of nerve damage during various procedures, including ENT and ...

The FDA released guidance Aug. 6 on the Medtronic NIM Vital Nerve Monitoring System recall. The recall is in response to 10 reported injuries resulting from false negative responses received while ...

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Medtronic recently completed a clinical ...

The NIM-Response® 3.0 and NIM-Neuro® 3.0 offer advanced nerve monitoring technology with an easy-to-use interface. NIM® systems monitor EMG activity from multiple mucles. If there is a change in nerve ...